Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via its unique partnership with the University of Oxford, the world’s #1 research university. This partnership enables OSE to work with the brightest academic minds tackling the world’s toughest challenges and guarantees unrivalled access to their scientific research. In collaboration with its global network of entrepreneurs and advisers, OSE goes well beyond funding to shape and nurture these complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, and Deep Tech – the company adopts a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience. To date, OSE has invested £0.6 billion in over 80 ambitious companies built on Oxford science

Borealis Ventures is an  early stage  venture capital firm that partners with entrepreneurs driving  innovation in healthcare and the Built Environment. The firm’s healthcare investing centres on life science platforms and digital health opportunities, and often involves commercializing university research. Current life science portfolio companies include Adimab (antibody discovery), Avitide (affinity purification), and Compass Therapeutics (immuno-oncology and autoimmune therapeutics).

Perivoli Innovations, which is wholly owned by the Perivoli Trust, invests in opportunities presented by the commercialisation of early stage life science, medical, digital, and other new technologies spinning mainly out of UK universities. It also invests in new businesses evolving around the digitalisation of money in East Africa. Its purpose is to fund the Perivoli Schools Trust which focuses on improving the quality of nursery schools in sub-Saharan Africa.

Ranked number one in the world in the 2021 Times Higher Education World Rankings, Oxford is at the forefront of the full range of academic disciplines, including medical sciences; mathematical, physical and life sciences; humanities; and social sciences. As the oldest university in the English-speaking world, it has long traditions of scholarship, but is also forward-looking, creative and cutting-edge. Oxford is one of Europe’s most entrepreneurial universities: ranking first in the UK for university spinouts, with more than 200 companies created to date. It is also recognised as a leader in support for social enterprise.

RT Capital is a leading specialist investor in the commercialization of global university IP